High payload capacity optimizes potential for therapeutic activity: Accommodates high API concentrations, i.e. 3.9% rapamycin.
Limited systemic absorption: Delivers large molecular weight molecules to dermis while overcoming 500 Dalton Rule.
Favorable patient tolerability: Precisely selected composition of inactive excipients enables chronic dosing for lifelong genetic diseases.
Scalable cGMP process: Physical and chemical stability at room temperature providing for long-term shelf life.
  • Delivering rapamycin directly to the site of disease, usually within the deep layers of the epidermis or dermis. An anhydrous gel keeps the 3.9% rapamycin fully dissolved, helping it penetrate the skin.
  • Keeping rapamycin stable, since it tends to form crystals and break down. QTORIN™ rapamycin did not form crystals in stability testing and stays stable at room temperature in our pump dispenser for long periods.
  • Offering a high-strength formula designed to work where it is applied, with little of the drug absorbed into the bloodstream.

  • Delivering pitavastatin directly to the site of disease, usually within the deep layers of the epidermis or dermis.
  • Keeping pitavastatin stable, since it tends to break down easily. The QTORIN™ pitavastatin formula stays stable at room temperature in our pump dispenser for long periods.
  • Offering a high-strength formula designed to work where it is applied, with little of the drug absorbed into the bloodstream.

View Publications
Skip to content